Synchron Raises $200 Million Series D to Advance Brain-Computer Interface Technology
Synchron secured $200 million in Series D funding to accelerate the commercialization of its Stentrode™ brain-computer interface (BCI) platform. The investment will also support the expansion of their AI and engineering teams in New York and San Diego.
About the Stentrode™ Platform
The Stentrode™ is an endovascular electrode array designed to enable brain-computer communication without invasive brain surgery.
Photo caption: The Stentrode™ Endovascular Electrode Array
Photo credit: Synchron
Media Contact
- Kimberly Ha
- Email: [email protected]
Synchron’s funding milestone marks a significant step in making brain-computer interface technology accessible and practical for medical use.
Would you like the summary sentence to be more technical or more accessible to a general audience?